Serum levels of interleukin-6 are linked to the severity of the disease caused by Andes Virus

Autor: Lilian Vera, Marcela Ferrés, Marcelo López-Lastra, Claudia Marco, Héctor Galeno, Jenniffer Angulo, Andrea Bermúdez, Eliecer Villagra, Constanza Martínez-Valdebenito, Judith Mora, Natalia Lagos, Natalia Becerra, Janepsy Díaz
Jazyk: angličtina
Rok vydání: 2017
Předmět:
0301 basic medicine
Male
RNA viruses
Orthohantavirus
Pulmonology
Physiology
Andes virus
Pathology and Laboratory Medicine
Gastroenterology
Severity of Illness Index
Geographical locations
Risk Factors
Immune Physiology
Bunyaviruses
Medicine and Health Sciences
Young adult
Chile
Child
Aged
80 and over

Innate Immune System
biology
Headaches
lcsh:Public aspects of medicine
Middle Aged
Hospitals
Infectious Diseases
Medical Microbiology
Child
Preschool

Viral Pathogens
Viruses
Disease Progression
Cytokines
Female
Pathogens
Research Article
Hantavirus
Adult
medicine.medical_specialty
lcsh:Arctic medicine. Tropical medicine
Adolescent
Infectious Disease Control
lcsh:RC955-962
030106 microbiology
Immunology
Hantavirus Pulmonary Syndrome
Microbiology
03 medical and health sciences
Young Adult
Age Distribution
Signs and Symptoms
Diagnostic Medicine
Internal medicine
Severity of illness
medicine
Humans
Sex Distribution
Interleukin 6
Microbial Pathogens
Aged
Hantavirus pulmonary syndrome
Chile (Country)
business.industry
Interleukin-6
Andes Virus
Public Health
Environmental and Occupational Health

Case-control study
Infant
Newborn

Organisms
Infant
Biology and Life Sciences
lcsh:RA1-1270
Molecular Development
South America
Surgery
Health Care
030104 developmental biology
Logistic Models
Health Care Facilities
Case-Control Studies
Immune System
Multivariate Analysis
Respiratory Infections
Etiology
biology.protein
People and places
business
Developmental Biology
Zdroj: PLoS Neglected Tropical Diseases, Vol 11, Iss 7, p e0005757 (2017)
PLoS Neglected Tropical Diseases
ISSN: 1935-2735
1935-2727
Popis: Andes virus (ANDV) is the etiological agent of hantavirus cardiopulmonary syndrome in Chile. In this study, we evaluated the profile of the pro-inflammatory cytokines IL-1β, IL-12p70, IL-21, TNF-α, IFN-γ, IL-10 and IL-6 in serum samples of ANDV-infected patients at the time of hospitalization. The mean levels of circulating cytokines were determined by a Bead-Based Multiplex assay coupled with Luminex detection technology, in order to compare 43 serum samples of healthy controls and 43 samples of ANDV-infected patients that had been categorized according to the severity of disease. When compared to the controls, no significant differences in IL-1β concentration were observed in ANDV-infected patients (p = 0.9672), whereas levels of IL-12p70 and IL-21 were significantly lower in infected cases (p =
Author summary Andes virus (ANDV) causes hantavirus cardiopulmonary syndrome (HCPS) that is characterized by the development of vascular leakage syndrome, eventually leading to massive pulmonary edema, shock and, in many cases, death. To date, no FDA-approved immunotherapeutics, specific antivirals, or vaccines are available for use against HCPS. Patient survival rates hinge largely on early virus diagnosis, hospital admission and aggressive pulmonary and hemodynamic support in an intensive care unit. Individual host factors associated with the outcome of an ANDV infection are poorly known, and such knowledge could allow the disease progression of hospitalized patients to be predicted, resulting in individualized treatment. In this study, we show that serum levels of IL-6 at the time of hospitalization in ANDV-infected patients are associated with the severity of the clinical outcome of ANDV-induced disease. Therefore, these finding suggest that determining IL-6 levels at the time of admission to the hospital could be useful to predict the progression of ANDV-induced disease.
Databáze: OpenAIRE